1. Home
  2. ATNM vs GSIT Comparison

ATNM vs GSIT Comparison

Compare ATNM & GSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • GSIT
  • Stock Information
  • Founded
  • ATNM 2000
  • GSIT 1995
  • Country
  • ATNM United States
  • GSIT United States
  • Employees
  • ATNM N/A
  • GSIT N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • GSIT Semiconductors
  • Sector
  • ATNM Health Care
  • GSIT Technology
  • Exchange
  • ATNM Nasdaq
  • GSIT Nasdaq
  • Market Cap
  • ATNM 56.5M
  • GSIT 67.4M
  • IPO Year
  • ATNM N/A
  • GSIT N/A
  • Fundamental
  • Price
  • ATNM $1.51
  • GSIT $2.51
  • Analyst Decision
  • ATNM Strong Buy
  • GSIT
  • Analyst Count
  • ATNM 5
  • GSIT 0
  • Target Price
  • ATNM $14.20
  • GSIT N/A
  • AVG Volume (30 Days)
  • ATNM 245.6K
  • GSIT 173.0K
  • Earning Date
  • ATNM 11-26-2024
  • GSIT 10-24-2024
  • Dividend Yield
  • ATNM N/A
  • GSIT N/A
  • EPS Growth
  • ATNM N/A
  • GSIT N/A
  • EPS
  • ATNM N/A
  • GSIT N/A
  • Revenue
  • ATNM $81,000.00
  • GSIT $19,691,000.00
  • Revenue This Year
  • ATNM $186.10
  • GSIT N/A
  • Revenue Next Year
  • ATNM $19,248.94
  • GSIT N/A
  • P/E Ratio
  • ATNM N/A
  • GSIT N/A
  • Revenue Growth
  • ATNM 80.00
  • GSIT N/A
  • 52 Week Low
  • ATNM $1.33
  • GSIT $1.88
  • 52 Week High
  • ATNM $10.24
  • GSIT $6.02
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 36.23
  • GSIT 30.85
  • Support Level
  • ATNM $1.82
  • GSIT $3.00
  • Resistance Level
  • ATNM $1.97
  • GSIT $3.20
  • Average True Range (ATR)
  • ATNM 0.12
  • GSIT 0.21
  • MACD
  • ATNM -0.02
  • GSIT -0.08
  • Stochastic Oscillator
  • ATNM 11.52
  • GSIT 4.55

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

Share on Social Networks: